Monarch Global Labs

Monarch Global Labs was paid $81K by Medicaid between Aug 2022 and Jun 2023, across 5 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 49% of everything it billed.

33Billing provider infoMONARCH GLOBAL LABS
MELBOURNE, FL 32901

33aNPI1700531720assigned 02/17/2022

33bProvider typeClinical Medical Laboratory

28Total paid$81K

24GClaims5,766

24DCodes billed5

24AFirst – last monthAug 2022 – Jun 2023

Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#111 of 225

Median peer was paid$74K

This provider vs. median1.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	3,109	$37K
2023	2,657	$44K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	49%	1,554	399	$39K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	23%	425	138	$18K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	16%	1,554	400	$13K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	11%	2,087	514	$9K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.2%	146	56	$991.24

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBIDDIX, THOMAS (CEO)

Same official

Other billing entities under BIDDIX, THOMAS

Full network →

Provider	Location	Paid
Screen and Confirm, LLC	Melbourne, FL	$5K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.